Logo.jpg
NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES
27 mars 2024 08h30 HE | Lixte Biotechnology Holdings, Inc.
LB-100 IS SYNERGISTIC WITH WEE1 INHIBITION IN KILLING CANCER CELLS; FINDING OPENS NEW TREATMENT STRATEGY IN ADDITION TO THREE CURRENT LIXTE CLINICAL TRIALS PASADENA, CA, March 27, 2024 (GLOBE...
MicrosoftTeams-image (5).png
Small Cell Lung Cancer Therapeutics Market Value to Exceed of USD 12.9 Bn by 2031, rising at a 11.9% CAGR: TMR Report
05 mai 2023 12h30 HE | Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global small cell lung cancer therapeutics market was valued at USD 4.6 Bn in 2022 and is projected to expand at a CAGR of...
Qualigen-Logo-Tag.png
Qualigen Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
12 déc. 2022 08h30 HE | Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for...
Straits Research Pvt Ltd
Solid Tumour Testing Market Size is projected to reach USD 40 Billion by 2030, growing at a CAGR of 6.2%: Straits Research
16 août 2022 11h30 HE | Straits Research
New York, United States, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Solid Tumors Form when cancerous tissues accumulate. Solid tumors are not cystic or liquid. Depending on their characteristics, solid...
provectus_logo.jpg
Provectus Announces Presentation of Initial Results from Phase 1B Trial of PV-10® in Combination with KEYTRUDA® for Treatment of Checkpoint-Refractory Advanced Melanoma at SMR 2019 Congress
21 nov. 2019 10h19 HE | Provectus Biopharmaceuticals Inc.
First 10 checkpoint-refractory melanoma patients treatedEstablished safety profiles of PV-10 and KEYTRUDA were maintained20% ORR and 40% DCR (RECIST 1.1)Changes in immune system activation biomarkers...
Logo.jpg
ALGAE DYNAMICS CORP SECURES US $250,000 INVESTMENT FROM TEEWINOT LIFE SCIENCES CORPORATION
15 nov. 2017 09h00 HE | Algae Dynamics Corporation
Toronto, ON, Nov. 15, 2017 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), a developer of unique health products utilizing cannabis and...